Sarah Aebersold - 11 Jul 2024 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Human Resources Officer
Signature
/s/ Sarah Aebersold
Issuer symbol
BLFS
Transactions as of
11 Jul 2024
Net transactions value
-$17,536
Form type
4
Filing time
18 Sep 2024, 17:45:03 UTC
Previous filing
03 Jul 2024
Next filing
01 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Sale $3,841 -187 -0.3% $20.54 61,496 11 Jul 2024 Direct F1
transaction BLFS Common Stock Sale $6,303 -300 -0.49% $21.01 61,196 19 Jul 2024 Direct F2
transaction BLFS Common Stock Sale $1,639 -64 -0.1% $25.61 61,132 21 Aug 2024 Direct F3
transaction BLFS Common Stock Sale $5,752 -229 -0.37% $25.12 60,903 16 Sep 2024 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F2 The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 07-17-2020 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F3 The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-08-2021 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.
F4 The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.